Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "Von Willebrand disease"
Show Display Options
Download search resultsDownload the search results for:
"Von Willebrand disease" (46 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Study of Biostate® in Children With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
2 Completed Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate®
3 Completed Extension Study of Biostate in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
4 Completed Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: recombinant interleukin-11
5 Terminated A Study With OPTIVATE® in People With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
6 Completed National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Condition: Von Willebrand Disease
Intervention:
7 Terminated
Has Results
IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
8 Recruiting Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)
Condition: Von Willebrands Disease
Intervention:
9 Not yet recruiting Molecular and Clinical Profile of Von Willebrand Disease in Spain
Condition: Von Willebrand Disease
Intervention: Genetic: VWF gene analysis
10 Recruiting Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Other: Patients using wilate as standard of care
11 Withdrawn Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention:
12 Recruiting Study of Voncento® in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Voncento
13 Terminated Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
14 Completed Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand Factor (rVWF)
15 Completed A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.
Condition: vonWillebrand's Disease
Interventions: Biological: Optivate® (Human Coagulation Factor VIII);   Biological: Haemate P® (Human Coagulation Factor VIII)
16 Recruiting Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: plasma-derived FVIII/VWF concentrate Fanhdi
17 Completed
Has Results
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor (rVWF);   Drug: Placebo;   Biological: Recombinant factor VIIII (rFVIII)
18 Completed
Has Results
IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Oprelvekin, Interleukin 11, IL-11
19 Withdrawn A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Condition: Von Willebrand Disease
Intervention: Drug: ARC1779
20 Completed Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);   Biological: Marketed plasma-derived VWF/FVIII concentrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.